November 2017 - Dublin, Ireland
Meeting objectives:
- Give an overview of the health care systems in both countries.
- Provide a summary of the epidemiology, burden of disease and surveillance related to HPV and HPV related cancers in Ireland and the UK.
- Discuss successes, topical issues and challenges related to HPV vaccination and screening particular to Ireland and the different regions in UK.
- Gain insight in the various stakeholder perspectives.
- Propose recommendations for the way forward.
(pdf, 1.7 MB)
November 30, 2017
SESSION 1: OPENING AND OBJECTIVES
Chairs: Liudmila Mosina and Brenda Corcoran
- (pdf, 313 kB) by Simon Harris, MOH Ireland
- (pdf, 788 kB, )
Alex Vorsters, University of Antwerp, HPV Prevention and Control Board (Belgium)
SESSION 2: THE HEALTH CARE SYSTEMS IN IRELAND AND THE UK
Chairs: Liudmila Mosina & Brenda Corcoran
- (pdf, 2 MB)
Vanessa Saliba, Public Health England (UK) - (pdf, 501 kB)
Kevin Kelleher, Health Service Executive (Ireland)
SESSION 3: EPIDEMIOLOGY, BURDEN OF DISEASE AND SURVEILLANCE OF HPV AND HPV RELATED CANCERS IN IRELAND AND THE UK
Chairs: Mario Poljak & Scott Wittet
- (pdf, 891 kB)
Mairead O’Connor, National Cancer Registry Ireland - Surveillance of HPV; a focus on the UK
Kate Cuschieri, Royal Infirmary of Edinburgh (UK) - (pdf, 496 kB)
Lesley Anderson, Queen’s University Belfast (UK)
SESSION 4: PREVENTION AND CONTROL OF HPV IN IRELAND AND THE UK
Chairs: Mario Poljak and Scott Wittet
- (pdf, 1.3 MB)
Vanessa Saliba, Public Health England (UK) - (pdf, 3.2 MB)
Brenda Corcoran, Health Service Executive (Ireland)
SESSION 4: PREVENTION AND CONTROL OF HPV IN IRELAND AND THE UK (Cont'd)
Chairs: Susanne Krûger-Kjaer and Susan Wang
- (pdf, 276 kB)
Lucy Jessop, Public Health Agency (UK) - (pdf, 2 MB)
Paul Connors, Health Service Executive (Ireland) - Communication and the HPV vaccine. What do parents and teenagers in England think?
Louise Letley, Public Health England (UK) - Panel debate : impact of communication on coverage and vice versa
Moderator: Robert O’Connor
Panel: Susan Mitchel, Paul Connors, Grainne O’Rourke, Catherine Fegan, David Robert Grimes
SESSION 5: HPV AND HPV RELATED CANCER SCREENING PROGRAMMES IN IRELAND AND THE UK
Chairs: Margaret Stanley & Eduardo Franco
- (pdf, 3.1 MB)
Grainne Flannelly/John Gleeson, Cervical Check (Ireland) - (pdf, 377 kB)
Ruth Stubbs, Public Health England (UK) - (pdf, 3 MB)
Grzayna Stanczuk, Western Isles Hospital (UK) - HPV based screening implementation in Scotland and impact of immunisation
Tim Palmer, University of Edinburgh (UK)
SESSION 6: KEY NOTE
Chairs: Rob O'Connor & Bruce Gellin
- (pdf, 1.5 MB)
Doug Lowy, National Cancer Institute (US)
December 1, 2017
SESSION 7: CHALLENGES AND OPPORTUNITIES IN HPV CONTROL
Chairs: Margaret Stanley and Paolo Bonanni
- (pdf, 794 kB)
Poster: 'The HPV vaccine crisis' (pdf, 794 kB)
Donal Brennan, Mater Misericordiae University Hospital (Ireland) - Panel debate on HPV vaccination programmes and the role of health care providers
Moderator: Pierre Van Damme
Donal Brennan, Paolo Bonanni, Ros Quinlan - New developments in anal screening and implications of vaccine in MSM
Richard Gilson, University College London (UK) - (pdf, 1.2 MB)
Mark Jit, London School for Hygiene and Tropical Medicine (UK)
SESSION 8: THE PATIENT'S PERSPECTIVE
Chairs: Mira Kojouharova & Sharon Hanley
- (pdf, 876 kB)
Stefanie Veraghtert, The Big C (Belgium)
SESSION 9: THE WAY FORWARD: BREAK- OUT SESSIONS
Chairs: Alex Vorsters and Kate Cuschieri
- Break-out sessions:
(pdf, 179 kB)
Chair: Peter Baker
(pdf, 180 kB)
Chair: Doug Lowy
(pdf, 182 kB)
Chair: Liudmila Mosina
(pdf, 179 kB)
Chair: Mark Kane
- Presentations from the break-out sessions & discussion
SESSION 10: MEETING CONCLUSIONS
Chairs: Pierre Van Damme and Mark Kane
- (pdf, 488 kB) & feedback
Rob O’Connor & and Brenda Corcoran